nafenopin has been researched along with transforming growth factor alpha in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| James, NH; Roberts, RA | 1 |
| Chabicovsky, M; Grasl-Kraupp, B; Peter, B; Rossmanith, W; Schausberger, E; Schulte-Hermann, R | 1 |
2 other study(ies) available for nafenopin and transforming growth factor alpha
| Article | Year |
|---|---|
The peroxisome proliferator class of non-genotoxic hepatocarcinogens synergize with epidermal growth factor to promote clonal expansion of initiated rat hepatocytes.
Topics: Albumins; Animals; Biomarkers; Carcinogens; Cell Division; Cell Transformation, Neoplastic; Cells, Cultured; Clone Cells; Cocarcinogenesis; Colony-Forming Units Assay; Cytochrome P-450 CYP4A; Cytochrome P-450 Enzyme System; DNA Replication; Drug Synergism; Epidermal Growth Factor; Hyperplasia; Liver; Liver Neoplasms, Experimental; Male; Microbodies; Mixed Function Oxygenases; Nafenopin; Rats; Rats, Wistar; Transforming Growth Factor alpha | 1994 |
Follistatin overexpression in rodent liver tumors: a possible mechanism to overcome activin growth control.
Topics: Activins; Adenoma; Alternative Splicing; Animals; Blotting, Western; Carcinoma, Hepatocellular; Cell Division; Diethylnitrosamine; Follistatin; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Male; Mice; Mice, Inbred Strains; Nafenopin; Phenobarbital; Rats; Reference Values; RNA, Messenger; Transforming Growth Factor alpha; Tumor Cells, Cultured | 2002 |